A recent survey among Euripid members confirmed their interest in sharing not only concrete price information but also information on the application of Managed Entry Agreements for individual products. Currently, 13 countries share information on MEAs for all or selected products. Another priority that was recently confirmed by members is the provision of volume information. Since January 2021, eleven countries share this information on the platform, partly dating back to 2015. The Secretariat is working on integrating information from a few more countries.

Further priorities of members include information on prices of non-reimbursed medicines or their patent status.

Also all but one respondent confirmed that they are either satisfied or very satisfied with the current form of the database.

The 3rd Fair Pricing Forum took place online from 13-22 April 2021 and focused again on improving access to medicines and health products through fair pricing, following the inaugural forum held in the Netherlands in 2017 (10–11 May) and the second forum in South Africa in 2019 (11-13 April). WHO invited the Euripid Collaboration to present our work. The presentation gives an overview of the collaboration and the project and outlines Euripid activities in improving access to medicines. An important information is that all countries from the WHO Euro Region may apply for membership.

Link to presentation